Market revenue in 2023 | USD 220.6 million |
Market revenue in 2030 | USD 168.3 million |
Growth rate | -3.8% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care |
Key market players worldwide | Becton Dickinson & Co, BioMerieux SA, Bio-Rad Laboratories Inc, Abbott Laboratories, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Roche Holding AG, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 47.42% in 2023. Horizon Databook has segmented the Mexico molecular diagnostics market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.
According to the International Agency for Research on Cancer, in Mexico, around 202,923 individuals were diagnosed with cancer in 2020. The high prevalence of colorectal cancer can be attributed to increased risk factors, such as unhealthy dietary patterns, physical inactivity, and lack of awareness about cancer.
Healthcare institutions have undertaken initiatives to spread awareness through healthcare camps for early disease diagnosis. Moreover, R&D programs for the analysis of novel genetic biomarkers subsequently used for drug development are also increasing owing to the rising number of collaborations between biopharmaceutical companies and research institutes.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account